Trials / Completed
CompletedNCT04630015
Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 134 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study evaluates the effects of the Survivorship Wellness Group Program following active treatment, as well as to learn from Survivorship Wellness participants about their concerns regarding the current COVID-19 pandemic. This study may help to evaluate the impact of the survivorship program on patient well-being, provide evidence for use in grant application and publications, and ultimately inform the continued improvement of survivorship care.
Detailed description
PRIMARY OBJECTIVES: 1. To examine the feasibility and acceptability of implementing an interdisciplinary goal-setting clinical group program focused on domains of physical, psychological, and spiritual wellness for survivors of cancer at University of California San Francisco (UCSF). 2. To determine preliminary efficacy of the Survivorship Wellness intervention in regards to: 1. Increasing knowledge of and perceived confidence in execution of health behavior changes in domains of physical, emotional, and spiritual wellness for survivors of cancer. 2. Increasing quality of life. 3. Reducing symptoms of depression and anxiety. 4. Increasing physical activity. 3. To assess differences in patient wellbeing and in the impact of the Survivorship Wellness program during the period of COVID-19 and telehealth classes. OUTLINE: Patients complete surveys over 5-10 minutes at baseline (i.e. before participating in the program), and at 9 and 15 weeks follow up on the impact of COVID-19 on survivorship. Patients also complete a survey assessing how patients rate telehealth classes in the Survivorship Wellness program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey Administration | Participants will complete study specific survey |
Timeline
- Start date
- 2020-08-31
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
- First posted
- 2020-11-16
- Last updated
- 2023-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04630015. Inclusion in this directory is not an endorsement.